Total Voting Rights

RNS Number : 2665E

IXICO plc

02 November 2015

 



2 November 2015

IXICO plc

Total Voting Rights

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company') confirms that the Company's issued share capital consists of 15,215,664 ordinary shares of 50p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

IXICO plc	[phone]
Derek Hill, CEO
Susan Lowther, CFO
Charles Spicer, VP Corporate Development
Peel Hunt LLP (Nominated Adviser and Broker)	[phone]
James Steel
Oliver Jackson
Daniel Stewart & Company (Joint Broker)	[phone]
Martin Lampshire
David Coffman
FTI Consulting Limited (Investor Relations)	[phone]
Simon Conway
Mo Noonan
Matthew Moss

Notes to Editors

About IXICO

IXICO, the brain health company, uses its innovative and proprietary digital platform technologies to help those involved in researching and treating serious diseases to make rapid, informed decisions targeted at improving patient outcomes.  IXICO has significant experience working with global pharmaceutical and biotechnology companies supporting clinical studies in the field of neuro-degenerative disorders including dementia, Alzheimer's disease, Huntington's disease and Multiple Sclerosis. 

More information is available on www.ixico.com

 

END

 

 

TVRUGGMWGUPAGAP